Zonisamide Shows Promise for Children With Drug-Resistant Epilepsy
⚠️ Infant dosing/safety: medication and diet decisions for infants require individualized medical guidance.
Source: CNS neuroscience & therapeutics
Summary
A study was conducted to see how effective and safe the medication zonisamide is for children with developmental epileptic encephalopathy (DEE) or epileptic encephalopathy (EE). This research involved 127 children from a single center over a period from 2020 to 2025. The focus was on younger children and those who had not responded well to other treatments.
The results showed that about half of the children experienced a significant reduction in seizures after taking zonisamide for a year. Specifically, 51% to 55% of the children had at least a 50% decrease in seizures over the first year, and around 24% to 28% became completely seizure-free. The study also found that girls and children who had tried fewer medications before were more likely to respond well to zonisamide. While some children experienced side effects, like reduced appetite, most found the medication tolerable.
This study is important because it suggests that zonisamide can be a helpful option for children with difficult-to-treat epilepsy, including very young children. However, it is important to note that this study was conducted at one center and may not represent all children with epilepsy. More research is needed to confirm these findings and understand how zonisamide works for different groups of children.
Free: Seizure First Aid Quick Guide (PDF)
Plus one plain-language weekly digest of new epilepsy research.
Unsubscribe anytime. No medical advice.
